通过抑制ALDOB,MRTO4增强了糖解,以促进HC的进展
Yongyuan Zheng1, Yansong Huang1, Weibing Li1
1Department of Hepatology and Infectious Diseases, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China (mainland).
概括
核糖体成熟因子 (MRTO4) 促进肝细胞癌 (HCC) 的进展,通过加速糖解和抑制ALDOB. 针对MRTO4可能为HCC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢过程中的代谢.
背景情况:
- 核糖体成熟因子 (MRTO4) 在癌症中被上调.
- 在肝细胞癌 (HCC) 中MRTO4的作用及其对能量代谢的影响需要进一步研究.
研究的目的:
- 为了研究MRTO4在HCC中的预后价值.
- 探索MRTO4在HCC进展中的作用及其与能量代谢重编程的关联,特别是糖解.
主要方法:
- 从癌症基因组图谱 (TCGA) 中分析临床数据.
- 使用考克斯回归和名图构造进行预测分析.
- 分子生物学技术 (RT-qPCR,西式涂抹,CCK8,TUNEL等等) 已经被广泛应用. 评估MRTO4在HCC细胞增殖,入侵,亡和糖解中的作用.
- 生物信息分析 (GO,KEGG) 探索代谢途径的关联.
主要成果:
- 在HCC中,MRTO4被确定为一种独立的预后风险因素.
- MRTO4加速HCC细胞糖解,增殖和侵入,同时抑制细胞亡.
- MRTO4通过抑制阿尔多酶B (ALDOB) 来促进HCC的进展,从而加速糖解.
结论:
- 通过糖解调节,MRTO4在促进HCC进展方面发挥着重要作用.
- 抑制MRTO4为肝细胞癌提供了潜在的治疗策略.
更多相关视频
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
1.5K
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:46Electron Transport Chain: Complex I and II
13.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.0K